Discover 3,465 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,465
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Los Angeles CA, Whittier CA, Fountain Valley CA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase3, Recruiting
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Location: Los Angeles CA, La Jolla CA, San Francisco CA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06465810
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for
Non-Small Cell Lung Cancer
Location: Beverly Hills CA, Los Angeles CA, Torrance CA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT06767514
Phase3, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Los Angeles CA, Duarte CA, Irvine CA, Loma Linda CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase3, Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for
Biliary Tract Cancer
Location: Los Angeles CA, Duarte CA, Orange CA, Palo Alto CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07221253
Phase3, Recruiting
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Los Angeles CA, Fayetteville AR, Houston TX,
Sponsor: AstraZeneca
Sex: Male
Age: 18 - 70+
Code: NCT07181161
Phase1, Phase2, Recruiting
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
for
Urothelial Cancer, Bladder Cancer
Location: Los Angeles CA, Dallas TX, Peoria IL, Niles IL,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07129993
Phase2, Phase3, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Los Angeles CA, Duarte CA, Irvine CA, La Jolla CA,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase3, Recruiting
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
for
Non-small Cell Lung Cancer, Colorectal Carcinoma,
Location: Los Angeles CA, Duarte CA, Newport Beach CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06218914
Phase1, Recruiting
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Los Angeles CA, Palo Alto CA, Phoenix AZ, Tucson AZ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase3, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: Los Angeles CA, Stanford CA, San Francisco CA,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase3, Recruiting
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
for
Endometrial Cancer, Gastric Cancer,
Location: Los Angeles CA, Santa Rosa CA, Albuquerque NM,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05489211
Phase2, Recruiting
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
for
Advanced Solid Malignancies
Location: Los Angeles CA, San Francisco CA, San Antonio TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05417594
Phase1, Phase2, Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
for
Prostate Cancer,
Location: Los Angeles CA, Newport Beach CA, San Francisco CA,
Sponsor: Janux Therapeutics
Sex: Male
Age: 18 - 70+
Code: NCT05519449
Phase1, Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for
Solid Tumors With HRAS Alterations,
Location: Los Angeles CA, Phoenix AZ, Tucson AZ, Oklahoma City OK,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06026410
Phase1, Recruiting
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome